Other studies demonstrated that pharmacological inhibition or depletion of GSK3β by siRNA decreases osteosarcoma cell proliferation despite an increased nuclear translocation of β-catenin and expression of its target genes [25]. This evidence concerns the gene GSK3B and osteosarcoma.